The EU has approved Pfizer's $15 billion takeover of US rival Hospira after the pharma giant promised to sell certain drugs in light of competition concerns. Read more


Results show that the company's European biosimilar epoetin, Retacrit (epoetin zeta) was effective and well tolerated in the management of chemotherapy-induced anemia in patients with solid tumours, lymphoma and myeloma. Read more

To better understand where the generic market is heading, a panel discussion was held with CEOs of top generic pharmaceutical companies and key financial analysts at this year’s Generic Pharmaceutical Association (GPhA) annual meeting. Read more